Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lansoprazole | 1 | 2017 | 7 | 0.73 | Why? |
| Floxacillin | 1 | 2017 | 14 | 0.71 | Why? |
| Serotonin Uptake Inhibitors | 2 | 2018 | 149 | 0.54 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 451 | 0.48 | Why? |
| Diabetic Retinopathy | 1 | 2017 | 347 | 0.46 | Why? |
| Antidepressive Agents, Tricyclic | 1 | 2011 | 29 | 0.44 | Why? |
| Asthma | 7 | 2020 | 4383 | 0.44 | Why? |
| Electronic Health Records | 5 | 2021 | 3492 | 0.44 | Why? |
| Clinical Coding | 3 | 2021 | 172 | 0.39 | Why? |
| Renal Insufficiency, Chronic | 3 | 2018 | 2654 | 0.38 | Why? |
| Adrenal Cortex Hormones | 3 | 2021 | 6537 | 0.33 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.33 | Why? |
| United Kingdom | 16 | 2021 | 18046 | 0.31 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.29 | Why? |
| England | 9 | 2021 | 5116 | 0.26 | Why? |
| Water Pollutants, Chemical | 2 | 2019 | 410 | 0.25 | Why? |
| Liver | 1 | 2017 | 4007 | 0.24 | Why? |
| Databases, Factual | 8 | 2018 | 6248 | 0.24 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.24 | Why? |
| Proton Pump Inhibitors | 2 | 2017 | 377 | 0.24 | Why? |
| Cohort Studies | 15 | 2021 | 36005 | 0.23 | Why? |
| Intracranial Hemorrhages | 1 | 2011 | 1170 | 0.23 | Why? |
| Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 3832 | 0.23 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.22 | Why? |
| Acute Kidney Injury | 2 | 2018 | 5762 | 0.22 | Why? |
| Validation Studies as Topic | 2 | 2017 | 121 | 0.21 | Why? |
| Incidence | 8 | 2018 | 25622 | 0.20 | Why? |
| Drinking Water | 2 | 2019 | 145 | 0.20 | Why? |
| Halogenation | 1 | 2019 | 51 | 0.20 | Why? |
| Proportional Hazards Models | 7 | 2021 | 6543 | 0.19 | Why? |
| Anti-Infective Agents, Urinary | 1 | 2018 | 27 | 0.18 | Why? |
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2017 | 17 | 0.18 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2017 | 6166 | 0.18 | Why? |
| Omeprazole | 1 | 2017 | 21 | 0.18 | Why? |
| Osteoarthritis | 1 | 2021 | 205 | 0.18 | Why? |
| Administration, Inhalation | 2 | 2021 | 1647 | 0.17 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.16 | Why? |
| Cost Savings | 1 | 2019 | 296 | 0.16 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.16 | Why? |
| Hyperkalemia | 1 | 2018 | 140 | 0.16 | Why? |
| Prescriptions | 1 | 2017 | 258 | 0.15 | Why? |
| Water Purification | 1 | 2019 | 285 | 0.15 | Why? |
| Nebulizers and Vaporizers | 1 | 2019 | 497 | 0.15 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.15 | Why? |
| Drug Resistance | 1 | 2017 | 395 | 0.14 | Why? |
| Regression Analysis | 2 | 2020 | 2484 | 0.14 | Why? |
| Research Design | 4 | 2018 | 5830 | 0.13 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.13 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.13 | Why? |
| Risk Factors | 13 | 2021 | 71621 | 0.13 | Why? |
| Aged | 24 | 2021 | 215776 | 0.13 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.13 | Why? |
| Filtration | 1 | 2019 | 820 | 0.13 | Why? |
| Publications | 1 | 2018 | 463 | 0.12 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2018 | 694 | 0.12 | Why? |
| Overweight | 1 | 2018 | 916 | 0.12 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2018 | 669 | 0.12 | Why? |
| Propensity Score | 2 | 2018 | 2690 | 0.12 | Why? |
| Myocardial Infarction | 2 | 2018 | 3361 | 0.12 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.12 | Why? |
| Primary Health Care | 3 | 2021 | 4839 | 0.11 | Why? |
| Female | 28 | 2021 | 380317 | 0.11 | Why? |
| Male | 26 | 2021 | 367725 | 0.11 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 1454 | 0.11 | Why? |
| Skin, Artificial | 1 | 2009 | 6 | 0.10 | Why? |
| Drug Interactions | 1 | 2018 | 1653 | 0.10 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.10 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.10 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 1261 | 0.10 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.10 | Why? |
| Age Factors | 6 | 2021 | 21039 | 0.10 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.10 | Why? |
| Adult | 19 | 2021 | 244371 | 0.09 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.09 | Why? |
| Keratinocytes | 1 | 2009 | 119 | 0.09 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.09 | Why? |
| Humans | 37 | 2021 | 930598 | 0.09 | Why? |
| Skin Diseases, Bacterial | 1 | 2009 | 105 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| Diphosphonates | 1 | 2009 | 121 | 0.09 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.09 | Why? |
| Muscarinic Antagonists | 2 | 2020 | 176 | 0.09 | Why? |
| Thromboembolism | 1 | 2021 | 2101 | 0.09 | Why? |
| Tissue Engineering | 1 | 2009 | 190 | 0.09 | Why? |
| Atrial Flutter | 1 | 2009 | 143 | 0.08 | Why? |
| Patient Admission | 2 | 2021 | 5250 | 0.08 | Why? |
| Health Status | 1 | 2021 | 3259 | 0.08 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.08 | Why? |
| Stroke | 3 | 2018 | 8839 | 0.08 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.07 | Why? |
| Disinfection | 1 | 2019 | 2912 | 0.07 | Why? |
| Fibroblasts | 1 | 2009 | 839 | 0.07 | Why? |
| Spirometry | 2 | 2018 | 524 | 0.07 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.07 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.07 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.07 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.06 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 1510 | 0.06 | Why? |
| Retrospective Studies | 7 | 2020 | 105322 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.06 | Why? |
| Population Surveillance | 2 | 2017 | 4967 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.06 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.06 | Why? |
| Reproducibility of Results | 4 | 2018 | 11304 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Cerebral Palsy | 1 | 2021 | 156 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Adrenergic beta-Agonists | 1 | 2019 | 93 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.05 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.05 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.05 | Why? |
| Child | 5 | 2021 | 70012 | 0.05 | Why? |
| Anesthesia, Obstetrical | 1 | 2002 | 230 | 0.05 | Why? |
| Renal Elimination | 1 | 2018 | 62 | 0.05 | Why? |
| Probability | 2 | 2018 | 923 | 0.04 | Why? |
| Consumer Product Safety | 1 | 2018 | 57 | 0.04 | Why? |
| Lead | 1 | 2018 | 94 | 0.04 | Why? |
| Skin | 1 | 2009 | 2096 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| State Medicine | 2 | 2021 | 2847 | 0.04 | Why? |
| Smoking | 2 | 2020 | 3358 | 0.04 | Why? |
| Pharmacoepidemiology | 1 | 2017 | 84 | 0.04 | Why? |
| Biostatistics | 1 | 2017 | 116 | 0.04 | Why? |
| Down Syndrome | 1 | 2021 | 397 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Multimorbidity | 1 | 2021 | 703 | 0.04 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.04 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.04 | Why? |
| Case-Control Studies | 2 | 2011 | 17671 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2019 | 694 | 0.03 | Why? |
| North America | 1 | 2019 | 1400 | 0.03 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2017 | 282 | 0.03 | Why? |
| Atrial Fibrillation | 1 | 2009 | 2320 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Causality | 1 | 2017 | 857 | 0.03 | Why? |
| Delivery, Obstetric | 1 | 2002 | 1292 | 0.03 | Why? |
| Anti-Asthmatic Agents | 1 | 2017 | 427 | 0.03 | Why? |
| Social Class | 1 | 2020 | 1360 | 0.03 | Why? |
| Drug Prescriptions | 1 | 2021 | 1062 | 0.03 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.03 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.03 | Why? |
| Nephrology | 1 | 2017 | 546 | 0.03 | Why? |
| General Practice | 1 | 2019 | 718 | 0.03 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.03 | Why? |
| Disabled Persons | 1 | 2021 | 1152 | 0.03 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.03 | Why? |
| Etidronic Acid | 1 | 2009 | 3 | 0.03 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.03 | Why? |
| Alendronate | 1 | 2009 | 12 | 0.03 | Why? |
| Disease Progression | 2 | 2019 | 13580 | 0.02 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.02 | Why? |
| Drug Combinations | 1 | 2019 | 3852 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 645 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2002 | 3803 | 0.02 | Why? |
| Antipsychotic Agents | 1 | 2017 | 887 | 0.02 | Why? |
| Hemorrhage | 1 | 2021 | 3013 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Data Mining | 1 | 2014 | 767 | 0.02 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2018 | 1671 | 0.02 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Bone Density Conservation Agents | 1 | 2009 | 209 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Chronic Disease | 1 | 2021 | 5139 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| HIV-1 | 1 | 2020 | 3365 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Extraction, Obstetrical | 1 | 2002 | 11 | 0.02 | Why? |
| Episiotomy | 1 | 2002 | 10 | 0.02 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| United States | 2 | 2021 | 46150 | 0.01 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Obstetric Labor Complications | 1 | 2002 | 119 | 0.01 | Why? |
| Labor, Induced | 1 | 2002 | 186 | 0.01 | Why? |
| Maternal Age | 1 | 2002 | 244 | 0.01 | Why? |
| New South Wales | 1 | 2002 | 336 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Labor, Obstetric | 1 | 2002 | 257 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Cells, Cultured | 1 | 2009 | 5835 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Risk | 1 | 2009 | 5288 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Depression | 1 | 2018 | 14116 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.01 | Why? |
| Cesarean Section | 1 | 2002 | 2089 | 0.01 | Why? |
| Odds Ratio | 1 | 2002 | 5861 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Logistic Models | 1 | 2002 | 9089 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2002 | 53120 | 0.00 | Why? |
Douglas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(127)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_